8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      ABT-450 combined with ritonavir, in addition to ABT-333 and ribavirin: a race for an interferon-free regimen to cure HCV infection.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          J. Hepatol.
          Journal of hepatology
          Elsevier BV
          1600-0641
          0168-8278
          Oct 2013
          : 59
          : 4
          Affiliations
          [1 ] Hepatology Department, AP-HP, University Paris Diderot 7 and INSERM U773, CRB3, Beaujon Hospital, Clichy, France. Electronic address: tarik.asselah@bjn.aphp.fr.
          Article
          S0168-8278(13)00351-6
          10.1016/j.jhep.2013.05.020
          23707374
          d2c41d7b-46fb-43c2-a752-12840b71d447
          History

          Chronic hepatitis C,DAA,Direct-acting antivirals,NS5A inhibitors,PegIFN,RVR,Resistance,SVR,Safety,Sustained virological response,direct-acting antivirals,eRVR,extended rapid virological response,pegylated interferon,rapid virologic response,sustained virological response

          Comments

          Comment on this article